Must Read Rumors

Kate Middleton, Prince William and Prince Harry set to be part of mental health documentary

The royal trio will reportedly take part in a mental health documentary for their mental health campaign.

Kate Middleton will visit EACH hospice at Quidenham

The Duchess of Cambridge, née Kate Middleton, is set to visit East Anglia’s Children’s Quidenham hospice for the first time this month.

Kate Middleton at first 2017 engagement: ‘Parenting is tough’

The Duchess of Cambridge, née Kate Middleton, recently visited the Anna Freud Centre for Children and Families that focuses on early intervention for young children with mental health issues.

Prince Harry and Meghan Markle spent first holiday together in Norway

For their first vacation as a couple, Prince Harry and Meghan Markle flew to Norway to admire the Northern Lights.

Kate Middleton and Prince William’s 2016 Christmas card revealed

The Duke and Duchess of Cambridge, née Kate Middleton, have released their official holiday card.

Kate Middleton, Prince William and Prince Harry set to be part of mental health documentary
Kate Middleton will visit EACH hospice at Quidenham
Kate Middleton at first 2017 engagement: ‘Parenting is tough’
Prince Harry and Meghan Markle spent first holiday together in Norway
Kate Middleton and Prince William’s 2016 Christmas card revealed

The Bluetooth pill to appear in European hospitals soon

by Nicole
November 12, 2010 at 3:22 pm

Miniaturization has always been a safe way to remarkable advances in microprocessor industry, allowing not only the manufacturing of microchips, but also a greater degree of integration for equipment with a high degree of complexity.

One of the areas that most benefit this is medicine, a domain in which miniaturization has enabled the creation of more sophisticated prostheses, and intelligent diagnostic equipment, small enough to fit inside a capsule.

One of the first companies to bring such devices in mass production is Novartis AG Sweden, with its “Ingestible Event Marker.” Small enough to be incorporated into the pill capsules, this microchip, activated after ingestion by contact with the stomach acids, may send biometric information to assess the effectiveness of the administered drug.

Parameters such as body temperature, heart rate and movements of the patient can be monitored, as information is transmitted in real time via Bluetooth.

Initially, this technology will be used only for monitoring high-risk patients such as those undergoing transplant operations, but could be extended to other areas.

If tests show that adding such microchips does not change the curative properties of pills, the product could be approved for general use in European countries over the next 18 months.

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions